UBS ASSET MANAGEMENT AMERICAS LLC - G1 THERAPEUTICS INC ownership

G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 118 filers reported holding G1 THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
UBS ASSET MANAGEMENT AMERICAS LLC ownership history of G1 THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$106,1280.0%39,6000.0%0.00%
Q1 2023$106,128
+58.9%
39,600
+222.0%
0.00%
Q4 2022$66,789
-100.0%
12,300
-70.0%
0.00%
Q1 2022$311,684,000
-25.6%
41,0110.0%0.00%
Q4 2021$418,722,000
-23.9%
41,0110.0%0.00%
Q3 2021$550,368,000
-38.8%
41,0110.0%0.00%
Q2 2021$899,781,000
-1.9%
41,011
+7.6%
0.00%
Q1 2021$916,975,000
+50.4%
38,112
+12.5%
0.00%
Q4 2020$609,681,000
+109.1%
33,890
+34.3%
0.00%
Q3 2020$291,557,000
-49.6%
25,243
+5.8%
0.00%
Q2 2020$578,965,000
-75.1%
23,865
-88.7%
0.00%
-100.0%
Q1 2020$2,326,465,000
-65.1%
211,113
-16.3%
0.00%
-50.0%
Q4 2019$6,666,598,000
+19.7%
252,236
+3.2%
0.00%0.0%
Q3 2019$5,567,341,000
-27.2%
244,396
-2.0%
0.00%
-20.0%
Q2 2019$7,642,986,000
+238.6%
249,282
+83.3%
0.01%
+150.0%
Q1 2019$2,257,401,000
-12.9%
135,988
+0.5%
0.00%0.0%
Q4 2018$2,590,554,000
-67.0%
135,277
-9.8%
0.00%
-66.7%
Q3 2018$7,839,108,000149,9160.01%
Other shareholders
G1 THERAPEUTICS INC shareholders Q3 2018
NameSharesValueWeighting ↓
MPM BioImpact LLC 856,798$6,512,0001.75%
CHI Advisors LLC 488,635$3,714,0001.58%
Pinz Capital Management, LP 186,515$1,418,0000.88%
Lombard Odier Asset Management (Switzerland) SA 542,183$4,121,0000.32%
Rhenman & Partners Asset Management AB 316,137$2,403,0000.24%
Birchview Capital, LP 40,000$304,0000.22%
NEEDHAM INVESTMENT MANAGEMENT LLC 160,000$1,216,0000.18%
Tekla Capital Management LLC 423,869$3,221,0000.11%
Golden Green, Inc. 12,152$92,0000.08%
Virtus ETF Advisers LLC 15,188$115,0000.05%
View complete list of G1 THERAPEUTICS INC shareholders